Document is current
Any future updates will be listed below
-
Authors
Li, Xiaomeng
Fu, Guoxiang
Zhang, Long
Guan, Ruoyu
Tang, Peiyuan
Zhang, Jialing
Rao, Xinxin
Chen, Shengzhi
Xu, Xiaoya
Zhou, Yi
Deng, Yun
Lv, Tao
He, Xingfeng
Mo, Shaobo
Mu, Peiyuan
Gao, Jianjun
Hua, Guoqiang https://orcid.org/0000-0001-9274-8136
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82173461, 31670858)
- License Information
-
More Information
Article History
Received: 23 January 2022
Accepted: 14 May 2022
First Online: 26 May 2022
Declarations
:
: The use of mice was approved by the Institutional Animal Care and Use Committee of Fudan University. The use of patient-derived tumor organoids was approved by the Ethical Committee and Institutional Review Board of Fudan University Shanghai Cancer Center.
: Not applicable.
: GH is the scientific founder of D1 Medical Technology. GF is an inventor on patent related to organoid imaging assay. The remaining authors declare no competing interests.
